Differential sensitivity of human papillomavirus type 16+ and type 18+ cervical carcinoma cells to CD95-mediated apoptosis

International Journal of Cancer

Volumn 93, Issue 6, 2001, Pages 823-831

  Aguilar Lemarroy, Adriana ^a   Kirchhoff, Sabine ^a   Whitaker, Noel ^a   Gariglio, Patricio ^a   Hausen, Harald Zur ^b   Krammer, Peter H ^c   Rösl, Frank ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Apoptosis; CD95; Cervical cancer; Human papillomavirus; Immunological surveillance; Somatic cell hybrids

Indexed keywords

FAS ANTIGEN;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL HYBRIDIZATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HYBRID CELL; IMMUNOSURVEILLANCE; KERATINOCYTE; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; WART VIRUS;

ANTIGENS, CD95; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA; CASPASE 3; CASPASE 8; CASPASE 9; CASPASES; CELL SEPARATION; CYCLOHEXIMIDE; DNA FRAGMENTATION; DOWN-REGULATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME ACTIVATION; FEMALE; FLOW CYTOMETRY; HELA CELLS; HUMANS; JURKAT CELLS; LIGANDS; MEMBRANE POTENTIALS; MITOCHONDRIA; PAPILLOMAVIRIDAE; PHENOTYPE; PROTEIN SYNTHESIS INHIBITORS; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 0035885269     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1405     Document Type: Article

References (67)

1. Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis
2. Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma
3. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes
4. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
5. Human papillomavirus type 16 E7 regulates E2F and contributes to mitogenic signalling
6. Human papillomavirus type 16 E7 associates with a histone Hi kinase and with p107 through sequences necessary for transformation
7. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins
8. Pathogenesis of cancer of the cervix
9. The possible role of chemokines in HPV-linked carcinogenesis
10. Integration of high-risk human papillomavirus DNA is linked to the down-regulation of class I human leukocyte antigens by steroid hormones in cervical tumor cells
11. Comparative lymphokine secretion by cultured normal human cervical keratinocytes, papillomavirus-immortalized, and carcinoma cell lines
12. Monocytechemo-attractant-protein-1 (MCP-1)-gene expression in cervical intra-epithelial neoplasias and cervical carcinomas
13. Association between cervical neoplasia and apoptosis as detected by in situ nuclear labeling
14. The CD95(APO-1/Fas)/CD95L system
15. Modulation of caspase-8 and FLICE-inhibitory protein expression as a potential mechanism of Epstein-Barr virus tumorigenesis in Burkitt's lymphoma
16. Induction of Bcl-x(L) expression by human T-cell leukemia virus type 1 Tax through NF-kappaB in apoptosis-resistant T-cell transfectants with Tax
17. Regulation of apoptosis by viral gene products
18. Ultraviolet radiation-induced apoptosis is mediated by activation of CD- 95 (Fas/APO-1)
19. Selective down-regulation of human papillomavirus transcription by 2-deoxyglucose
20. Specific and rapid induction of the proapoptotic protein Hrk after growth factor withdrawal in hematopoietic progenitor cells
21. Activation of apoptosis pathways by anticancer treatment
22. Viral interference with apoptosis
23. Induction of apoptosis by p53 is independent of its oligomeric state and can be abolished by HPV-18 E6 through ubiquitin mediated degradation
24. Human papillomavirus type 16 E6 and HPV-16 E6/E7 sensitize human keratinocytes to apoptosis induced by chemotherapeutical agents: Role of p53 and caspase activation
25. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family
26. Monoclonal antibody-mediated tumor regression by induction of apoptosis
27. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor
28. Caspases: Enemies within
29. The genetic regulation of apoptosis
30. Extinction of the HPV18 upstream regulatory region in cervical carcinoma cells after fusion with non-tumorigenic human keratinocytes under non-selective conditions
31. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens
32. Two CD95 (APO-1/Fas) signaling pathways
33. Structure of the human APO-1 gene
34. FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b
35. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis
36. Cycloheximide-induced T-cell death is mediated by a Fas-associated death domain-dependent mechanism
37. Human cell hybrids: Analysis of transformation and tumorigenicity
38. Inhibition of death receptor signals by cellular FLIP
39. The role of c-FLIP in modulation of CD95-induced apoptosis
40. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis
41. Mechanisms of apoptosis by c-Myc
42. The p53 pathway and apoptosis
43. The Bcl-2 protein family: Arbiters of cell survival
44. Activation of p21WAF1/Cip1 expression by a temperature-sensitive mutant of human p53 does not lead to apoptosis
45. Inhibition of apoptosis by the retinoblastoma gene product
46. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis
47. Mitochondria and apoptosis
48. The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death
49. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC)
50. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand
51. Evidence for trans regulation of apoptosis in intertypic somatic cell hybrids
52. The E7 protein of human papillomavirus type 16 sensitizes primary human keratinocytes to apoptosis
53. Human papillomavirus type 16 E7 protein sensitizes cervical keratinocytes to apoptosis and release of interleukin-1alpha
54. Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium
55. Fas/APO-I (CD95) is not translocated to the cell membrane in esophageal adenocarcinoma
56. Somatic Fas mutations in non-Hodgkin's lymphoma: Association with extranodal disease and autoimmunity
57. Cultivated H-RS cells are resistant to CD95L-mediated apoptosis despite expression of wild-type CD95
58. Bcl-2 proteins: Regulators of apoptosis or of mitochondrial homeostasis?
59. Expression level of Bcl-2 determines anti- or proapoptotic function
60. L functions downstream of caspase-8 to inhibit Fas- and tumor necrosis factor receptor 1-induced apoptosis of MCF7 breast carcinoma cells
61. Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway
62. Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis
63. The biochemistry of programmed cell death
64. Death receptors: Signaling and modulation
65. The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes
66. The viral transcriptional regulatory region upstream of the E6 and E7 genes is a major determinant of the differential immortalization activities of human papillomavirus types 16 and 18
67. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective